Oui, les AVC sont une complication fréquente et peuvent survenir à tout moment.
Accident vasculaire cérébralComplicationsMaladie de Moya-Moya
#3
Y a-t-il des risques de récidive d'AVC ?
Oui, les patients ont un risque accru de récidive d'AVC même après un traitement.
RécidiveAccident vasculaire cérébralMaladie de Moya-Moya
#4
Les complications peuvent-elles affecter la qualité de vie ?
Oui, les complications neurologiques peuvent significativement altérer la qualité de vie des patients.
Qualité de vieComplicationsMaladie de Moya-Moya
#5
Comment les complications sont-elles gérées ?
Les complications sont gérées par des soins médicaux appropriés et une réhabilitation ciblée.
Gestion des complicationsRéhabilitationMaladie de Moya-Moya
Facteurs de risque
5
#1
Quels sont les principaux facteurs de risque de Moya-Moya ?
Les antécédents familiaux, les maladies auto-immunes et certaines conditions génétiques sont des facteurs de risque.
Antécédents familiauxMaladies auto-immunesFacteurs de risque
#2
La race influence-t-elle le risque de Moya-Moya ?
Oui, la maladie est plus fréquente chez les personnes d'origine asiatique, notamment au Japon.
Origine ethniqueMaladie de Moya-MoyaFacteurs de risque
#3
L'âge joue-t-il un rôle dans le risque ?
Oui, la maladie de Moya-Moya est souvent diagnostiquée chez les enfants et les jeunes adultes.
ÂgeMaladie de Moya-MoyaFacteurs de risque
#4
Les maladies cardiovasculaires augmentent-elles le risque ?
Oui, les maladies cardiovasculaires peuvent augmenter le risque d'accidents vasculaires cérébraux associés.
Maladies cardiovasculairesAccident vasculaire cérébralMaladie de Moya-Moya
#5
Le tabagisme est-il un facteur de risque ?
Oui, le tabagisme est un facteur de risque connu qui peut aggraver la santé vasculaire.
TabagismeSanté vasculaireFacteurs de risque
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Maladie de Moya-Moya : Questions médicales les plus fréquentes",
"headline": "Maladie de Moya-Moya : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Maladie de Moya-Moya : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-03",
"dateModified": "2026-02-23",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Maladie de Moya-Moya"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Artériopathies cérébrales",
"url": "https://questionsmedicales.fr/mesh/D002539",
"about": {
"@type": "MedicalCondition",
"name": "Artériopathies cérébrales",
"code": {
"@type": "MedicalCode",
"code": "D002539",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C14.907.253.560.200"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Maladie de Moya-Moya",
"alternateName": "Moyamoya Disease",
"code": {
"@type": "MedicalCode",
"code": "D009072",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Miki Fujimura",
"url": "https://questionsmedicales.fr/author/Miki%20Fujimura",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Takeshi Funaki",
"url": "https://questionsmedicales.fr/author/Takeshi%20Funaki",
"affiliation": {
"@type": "Organization",
"name": "Department of Neurosurgery, Kyoto University Graduate School of Medicine."
}
},
{
"@type": "Person",
"name": "Teiji Tominaga",
"url": "https://questionsmedicales.fr/author/Teiji%20Tominaga",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Qian Zhang",
"url": "https://questionsmedicales.fr/author/Qian%20Zhang",
"affiliation": {
"@type": "Organization",
"name": "Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China."
}
},
{
"@type": "Person",
"name": "Dong Zhang",
"url": "https://questionsmedicales.fr/author/Dong%20Zhang",
"affiliation": {
"@type": "Organization",
"name": "Department of Neurosurgery, Beijing Hospital, National Center of Gerontology, Beijing, China. zhangdong0660@aliyun.com."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Research progress on moyamoya disease combined with thyroid diseases.",
"datePublished": "2023-10-11",
"url": "https://questionsmedicales.fr/article/37900127",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fendo.2023.1233567"
}
},
{
"@type": "ScholarlyArticle",
"name": "Technical evolution of pediatric neurosurgery: moyamoya disease.",
"datePublished": "2023-07-03",
"url": "https://questionsmedicales.fr/article/37395784",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00381-023-06017-9"
}
},
{
"@type": "ScholarlyArticle",
"name": "Five-Year Stroke Risk and Its Predictors in Asymptomatic Moyamoya Disease: Asymptomatic Moyamoya Registry (AMORE).",
"datePublished": "2023-05-22",
"url": "https://questionsmedicales.fr/article/37216455",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1161/STROKEAHA.122.041932"
}
},
{
"@type": "ScholarlyArticle",
"name": "Outcomes of Bypass Surgery in Adult Moyamoya Disease by Onset Type.",
"datePublished": "2024-06-03",
"url": "https://questionsmedicales.fr/article/38842810",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1001/jamanetworkopen.2024.15102"
}
},
{
"@type": "ScholarlyArticle",
"name": "Characterization of PANoptosis-related genes and the immune landscape in moyamoya disease.",
"datePublished": "2024-05-04",
"url": "https://questionsmedicales.fr/article/38704490",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-024-61241-w"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies cardiovasculaires",
"item": "https://questionsmedicales.fr/mesh/D002318"
},
{
"@type": "ListItem",
"position": 3,
"name": "Maladies vasculaires",
"item": "https://questionsmedicales.fr/mesh/D014652"
},
{
"@type": "ListItem",
"position": 4,
"name": "Angiopathies intracrâniennes",
"item": "https://questionsmedicales.fr/mesh/D002561"
},
{
"@type": "ListItem",
"position": 5,
"name": "Artériopathies intracrâniennes",
"item": "https://questionsmedicales.fr/mesh/D020765"
},
{
"@type": "ListItem",
"position": 6,
"name": "Artériopathies cérébrales",
"item": "https://questionsmedicales.fr/mesh/D002539"
},
{
"@type": "ListItem",
"position": 7,
"name": "Maladie de Moya-Moya",
"item": "https://questionsmedicales.fr/mesh/D009072"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Maladie de Moya-Moya - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Maladie de Moya-Moya",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-04-28",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Maladie de Moya-Moya",
"description": "Comment diagnostique-t-on la maladie de Moya-Moya ?\nQuels tests sont utilisés pour confirmer le diagnostic ?\nQuels signes cliniques indiquent Moya-Moya ?\nLa génétique joue-t-elle un rôle dans le diagnostic ?\nQuels médecins sont impliqués dans le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D009072#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Maladie de Moya-Moya",
"description": "Quels sont les symptômes courants de Moya-Moya ?\nLes enfants peuvent-ils avoir des symptômes différents ?\nComment les symptômes évoluent-ils dans le temps ?\nY a-t-il des symptômes spécifiques aux adultes ?\nLes symptômes peuvent-ils être confondus avec d'autres maladies ?",
"url": "https://questionsmedicales.fr/mesh/D009072#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Maladie de Moya-Moya",
"description": "Comment prévenir la maladie de Moya-Moya ?\nQuels facteurs de risque sont à surveiller ?\nLe mode de vie peut-il influencer la maladie ?\nLes examens réguliers sont-ils importants ?\nLa gestion du stress peut-elle aider ?",
"url": "https://questionsmedicales.fr/mesh/D009072#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Maladie de Moya-Moya",
"description": "Quels traitements sont disponibles pour Moya-Moya ?\nLa chirurgie est-elle toujours nécessaire ?\nQuels médicaments sont utilisés pour traiter Moya-Moya ?\nY a-t-il des traitements non chirurgicaux ?\nQuel est le rôle de la réhabilitation ?",
"url": "https://questionsmedicales.fr/mesh/D009072#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Maladie de Moya-Moya",
"description": "Quelles sont les complications possibles de Moya-Moya ?\nLes AVC sont-ils fréquents chez les patients ?\nY a-t-il des risques de récidive d'AVC ?\nLes complications peuvent-elles affecter la qualité de vie ?\nComment les complications sont-elles gérées ?",
"url": "https://questionsmedicales.fr/mesh/D009072#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Maladie de Moya-Moya",
"description": "Quels sont les principaux facteurs de risque de Moya-Moya ?\nLa race influence-t-elle le risque de Moya-Moya ?\nL'âge joue-t-il un rôle dans le risque ?\nLes maladies cardiovasculaires augmentent-elles le risque ?\nLe tabagisme est-il un facteur de risque ?",
"url": "https://questionsmedicales.fr/mesh/D009072#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostique-t-on la maladie de Moya-Moya ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'angiographie cérébrale et l'imagerie par résonance magnétique."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour confirmer le diagnostic ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'angiographie par résonance magnétique et la tomodensitométrie sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques indiquent Moya-Moya ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes neurologiques comme des AVC récurrents ou des crises convulsives peuvent indiquer la maladie."
}
},
{
"@type": "Question",
"name": "La génétique joue-t-elle un rôle dans le diagnostic ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux peuvent suggérer une prédisposition génétique à la maladie."
}
},
{
"@type": "Question",
"name": "Quels médecins sont impliqués dans le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les neurologues et les radiologues sont généralement impliqués dans le diagnostic de cette maladie."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants de Moya-Moya ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des maux de tête, des AVC, des troubles de la vision et des convulsions."
}
},
{
"@type": "Question",
"name": "Les enfants peuvent-ils avoir des symptômes différents ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, chez les enfants, les symptômes peuvent inclure des retards de développement et des crises fréquentes."
}
},
{
"@type": "Question",
"name": "Comment les symptômes évoluent-ils dans le temps ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent s'aggraver progressivement, avec des épisodes d'AVC de plus en plus fréquents."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes spécifiques aux adultes ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les adultes peuvent éprouver des troubles cognitifs et des changements d'humeur en plus des AVC."
}
},
{
"@type": "Question",
"name": "Les symptômes peuvent-ils être confondus avec d'autres maladies ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent être similaires à ceux d'autres troubles neurologiques, rendant le diagnostic difficile."
}
},
{
"@type": "Question",
"name": "Comment prévenir la maladie de Moya-Moya ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de prévention spécifique, mais la gestion des facteurs de risque est essentielle."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque sont à surveiller ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents familiaux, l'hypertension et le tabagisme sont des facteurs de risque importants."
}
},
{
"@type": "Question",
"name": "Le mode de vie peut-il influencer la maladie ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sain peut réduire le risque d'accidents vasculaires cérébraux associés."
}
},
{
"@type": "Question",
"name": "Les examens réguliers sont-ils importants ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des examens réguliers peuvent aider à détecter les signes précoces de la maladie."
}
},
{
"@type": "Question",
"name": "La gestion du stress peut-elle aider ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la gestion du stress peut contribuer à la santé globale et réduire les risques associés."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour Moya-Moya ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent la chirurgie de dérivation et des médicaments pour gérer les symptômes."
}
},
{
"@type": "Question",
"name": "La chirurgie est-elle toujours nécessaire ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, la chirurgie est recommandée en fonction de la gravité des symptômes et des AVC."
}
},
{
"@type": "Question",
"name": "Quels médicaments sont utilisés pour traiter Moya-Moya ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des anticoagulants et des antiplaquettaires sont souvent prescrits pour prévenir les AVC."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements non chirurgicaux ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la gestion des facteurs de risque et la rééducation sont des approches non chirurgicales."
}
},
{
"@type": "Question",
"name": "Quel est le rôle de la réhabilitation ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "La réhabilitation aide à récupérer les fonctions perdues après un AVC et à améliorer la qualité de vie."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles de Moya-Moya ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des AVC, des troubles cognitifs et des déficits neurologiques permanents."
}
},
{
"@type": "Question",
"name": "Les AVC sont-ils fréquents chez les patients ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les AVC sont une complication fréquente et peuvent survenir à tout moment."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques de récidive d'AVC ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les patients ont un risque accru de récidive d'AVC même après un traitement."
}
},
{
"@type": "Question",
"name": "Les complications peuvent-elles affecter la qualité de vie ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les complications neurologiques peuvent significativement altérer la qualité de vie des patients."
}
},
{
"@type": "Question",
"name": "Comment les complications sont-elles gérées ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications sont gérées par des soins médicaux appropriés et une réhabilitation ciblée."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque de Moya-Moya ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents familiaux, les maladies auto-immunes et certaines conditions génétiques sont des facteurs de risque."
}
},
{
"@type": "Question",
"name": "La race influence-t-elle le risque de Moya-Moya ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la maladie est plus fréquente chez les personnes d'origine asiatique, notamment au Japon."
}
},
{
"@type": "Question",
"name": "L'âge joue-t-il un rôle dans le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la maladie de Moya-Moya est souvent diagnostiquée chez les enfants et les jeunes adultes."
}
},
{
"@type": "Question",
"name": "Les maladies cardiovasculaires augmentent-elles le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les maladies cardiovasculaires peuvent augmenter le risque d'accidents vasculaires cérébraux associés."
}
},
{
"@type": "Question",
"name": "Le tabagisme est-il un facteur de risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme est un facteur de risque connu qui peut aggraver la santé vasculaire."
}
}
]
}
]
}
Moyamoya disease (MMD), also known as abnormal cerebral vascular network disease, is characterized by progressive occlusion or stenosis of the internal carotid and cerebral arteries, as well as the fo...
Moyamoya disease (MMD) is a rare steno-occlusive disease of the bilateral internal carotid arteries that predominantly occurs in East Asia. Since the first description of the MMD by Suzuki and Takaku ...
Long-term outcomes are unknown in patients with asymptomatic moyamoya disease. In this report, we aimed to clarify their 5-year risk of stroke and its predictors....
We are conducting a multicenter, prospective cohort study (Asymptomatic Moyamoya Registry) in Japan. Participants were eligible if they were 20 to 70 years, had bilateral or unilateral moyamoya diseas...
Between 2012 and 2015, we enrolled 109 patients, of whom 103 patients with 182 involved hemispheres completed the 5-year follow-up. According to the findings on DSA and MRA, 143 hemispheres were judge...
The hemispheres with asymptomatic moyamoya disease may carry a 1.0% annual risk of stroke during the first 5 years, the majority of which are hemorrhagic stroke. Grade-2 choroidal anastomosis may pred...
URL: https://www....
gov; Unique identifier: UMIN000006640....
Moyamoya disease (MMD) is a rare chronic cerebrovascular disease, and the outcomes of bypass management in adult patients remain controversial....
To categorize adult MMD based on asymptomatic, ischemic, and hemorrhagic onset and compare the outcomes (death, hemorrhagic stroke [HS], and ischemic stroke [IS]) of bypass surgery (direct or indirect...
This retrospective, nationwide, population-based longitudinal cohort study used Korean National Health Insurance Research data to identify adults (aged ≥15 years) with MMD who were diagnosed between J...
Bypass surgery and conservative management....
Death constituted the primary outcome; secondary outcomes consisted of HS or IS. Kaplan-Meier survival curve and Cox proportional hazards regression analysis were applied. The propensity score-matchin...
A total of 19 700 patients (mean [SD] age, 45.43 [14.98] years; 12 766 [64.8%] female) were included. Compared with conservative management, bypass was associated with a reduced risk of death (adjuste...
The findings of this cohort study of bypass outcomes for patients with MMD emphasize the importance of tailoring management strategies in adult patients based on onset types....
Moyamoya disease (MMD) is a cerebrovascular narrowing and occlusive condition characterized by progressive stenosis of the terminal portion of the internal carotid artery and the formation of an abnor...
This study investigated the effect of indirect revascularization surgery in adult patients with moyamoya disease (MMD) complicated with hyperhomocysteinemia (HHcy), and the effect of HHcy on the progr...
A retrospective case-control study was conducted in patients with MMD, with or without HHcy (n = 123). Postoperative collateral angiogenesis was evaluated using the Matsushima grading system and disea...
There was no significant difference in the Suzuki stage composition ratios between the HHcy group and the non-HHcy group before and after surgery. Non-HHcy patients were more likely to grow new collat...
HHcy level may be a specific predictor of adverse clinical outcomes after EDAS in patients with MMD and a risk factor for poor collateral circulation and poor prognosis. Patients with MMD complicated ...
To explore the applicability of CT perfusion-derived parameters and collateral index in prediction of functional and clinical outcomes in patients with Moyamoya disease (MMD) who have not been treated...
All hemispheres were categorized into four groups: those with ischemic (IS) lesions, hemorrhagic (HE) lesions, subarachnoid hemorrhage (SAH) and normal hemisphere (NH). The clinical review included pr...
Between December 2020 and December 2021, 21 MMD patients (15 bilateral cases and 6 unilateral cases, for a total of 36 hemispheres) were retrospectively included. Compared with the NH group, the IS gr...
Among different imaging types, IS hemispheres were characterized by distinct changes of hemodynamic parameters. Collateral index of HIR could be considered a clinically accessible and promising indict...
Moyamoya disease (MMD) is an idiopathic occlusive cerebrovascular disorder. The development of collateral circulation originates from the dural and pial collaterals. Currently, the clinical significan...
Data from MMD patients were collected at Xiangya Hospital from January 2016 to April 2022. A collateral circulation grading system with scores was established, the dominant side of transdural collater...
A total of 102 patients were recruited. Results of digital subtraction angiography showed that 74 (72.5%) patients had transdural collaterals. The transdural collaterals were more common in patients w...
Transdural collateral circulation was common in MMD patients. The transdural collaterals were associated with the occurrence of infarction. Transdural collaterals were well established on the cerebral...
Eventually, 108 consecutive patients received 174 surgeries were enrolled, experienced new or expanded infarction occured in 13 (7.47%) surgeries, which showed higher Suzuki stage on the non-operative...
Revascularization was a safe option for patients with MMD, higher Suzuki stage on the non-operative side, PCA involvement, and intraoperative hypotension might be the risk factors for new or expanded ...
When it comes to the onset of moyamoya disease (MMD), environmental variables are crucial. Furthermore, there is confusion about the relationship between the gut microbiome, an environmental variable,...
A prospective case-control investigation was performed from June 2021 to May 2022. The fecal samples of patients with MMD and HC were obtained. Typically, 16S rRNA sequencing was employed to examine t...
This investigation involved a total of 60 MMD patients and 60 HC. The MMD group's Shannon and Chao 1 indices were substantially lower than those of the HC cohort. β-diversity was significantly differe...
The gut microbiota was altered in individuals with MMD, and was characterized by increased abundance of...
